0001104659-21-130502.txt : 20211027 0001104659-21-130502.hdr.sgml : 20211027 20211027163220 ACCESSION NUMBER: 0001104659-21-130502 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20211027 DATE AS OF CHANGE: 20211027 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Healthcare Royalty, Inc. CENTRAL INDEX KEY: 0001859651 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-257590 FILM NUMBER: 211353422 BUSINESS ADDRESS: STREET 1: 300 ATLANTIC ST STREET 2: SUITE 600 CITY: STAMFORD STATE: CT ZIP: 06901 BUSINESS PHONE: (203) 487-8300 MAIL ADDRESS: STREET 1: 300 ATLANTIC ST STREET 2: SUITE 600 CITY: STAMFORD STATE: CT ZIP: 06901 RW 1 tm2131210d1_rw.htm RW

 

Healthcare Royalty, Inc.

300 Atlantic St, Suite 600

Stamford, Connecticut 06901

(203) 487-8300

October 27, 2021

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

 

  Re:   Healthcare Royalty, Inc.
     

Request to Withdraw Registration Statement on Form S-1

File No. 333-257590

 

Ladies and Gentlemen:

 

Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), Healthcare Royalty, Inc. (the “Company”) hereby requests that, effective as of the date first set forth above, the Securities and Exchange Commission (the “Commission”) consent to the withdrawal of the Company’s Registration Statement on Form S-1 (File No. 333-257590), together with all amendments and exhibits thereto (collectively, the “Registration Statement”). The Registration Statement was originally filed on July 1, 2021 and was amended on July 12, 2021, July 16, 2021, July 29, 2021, and August 3, 2021.

 

The Company submits this request for withdrawal as it does not intend to pursue the contemplated public offering of the securities covered by the Registration Statement at this time.

 

The Company confirms that the Registration Statement has not been declared effective, no securities have been or will be issued or sold pursuant to the Registration Statement or the prospectus contained therein and no preliminary prospectus contained in the Registration Statement has been distributed.

 

The Company further requests that, in accordance with Rule 457(p) of the Securities Act, all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use.

 

 

 

 

If you have any questions or require any further information, please contact the Company’s counsel, Morgan Lewis Bockius LLP, by calling Finnbarr D. Murphy at (212) 309-6704 or Andrew R. Mariniello at (215) 963-4947.

 

  Very truly yours,
   
  Healthcare Royalty, Inc.
     
  By: /s/ Christopher A. White
  Name: Christopher A. White
  Title: Chief Financial Officer

 

cc:Christopher A. White, Healthcare Royalty, Inc.
 Andrew R. Mariniello, Morgan Lewis Bockius LLP
 Finnbarr D. Murphy, Morgan Lewis Bockius LLP